| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/06/1996 | WO1996016929A1 Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods of preparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions |
| 06/06/1996 | WO1996016928A1 Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy |
| 06/06/1996 | WO1996016677A2 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
| 06/06/1996 | CA2206576A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents that contain these complexes and their use in diagnosis and therapy |
| 06/06/1996 | CA2206526A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | CA2206522A1 Novel, multiply substituted dtpa derivatives and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of complexing agents and complexes and process for the production of pharmaceutical agents |
| 06/06/1996 | CA2206397A1 Use of metal complexes as liver and gall bladder x-ray diagnostic agentsin computer tomography |
| 06/05/1996 | EP0714911A2 Somastotatin analogs containing chelating groups and their radiolabeled compositions |
| 06/05/1996 | EP0714405A1 Therapeutic and diagnostic agents for amyloidosis |
| 06/05/1996 | EP0714291A1 Lupane triterpenoid derivatives |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/04/1996 | US5523402 Tripyridyl macrocyclic compounds |
| 05/30/1996 | WO1996015830A1 X-ray emitting interstitial implants |
| 05/30/1996 | WO1996015816A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 05/30/1996 | WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 05/30/1996 | CA2205064A1 Stable n-terminally linked dtpa:protein compositions and methods |
| 05/29/1996 | EP0713513A1 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes |
| 05/29/1996 | CN1123186A Preparation method for electromagnetized health-care pill and electuary thereof |
| 05/28/1996 | US5521290 Reaction of maleimide groups of bifunctional linking compounds with molecules to be linked, then reacting remaining aldehyde and hydrazide groups of linking compounds |
| 05/28/1996 | CA2078996C A bifunctional dtpa-type ligand |
| 05/23/1996 | WO1996014881A1 Inclusion complex of a radiohalogenated fatty acid in a cyclodextrin |
| 05/23/1996 | WO1996014880A1 Method and apparatus for interstitial radiation of the prostate gland |
| 05/23/1996 | WO1996014879A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same |
| 05/23/1996 | CA2205360A1 Methods for use of novel lyoprotectants and instant kit formulations for radiopharmaceuticals using the same |
| 05/22/1996 | EP0712421A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| 05/22/1996 | EP0712315A1 Radiometal complexes that localise in hypoxic tissue |
| 05/22/1996 | EP0703791A4 An iodinated neuroprobe for mapping monoamine reuptake sites |
| 05/22/1996 | CN1031828C Process for preparing ligands and cationic complexes thereof with technetium-99m |
| 05/21/1996 | US5519008 Antiinflammatory agents |
| 05/21/1996 | US5518888 Imaging metastasized colorectal cancer, toxtin peptides less than 25 units |
| 05/21/1996 | US5518187 Method of grinding pharmaceutical substances |
| 05/21/1996 | US5517993 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 05/17/1996 | WO1996014339A1 Antibodies |
| 05/17/1996 | WO1996014091A1 Diagnostic preparation for detection of helicobacter pylori |
| 05/15/1996 | EP0711300A1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| 05/15/1996 | EP0711178A1 Blood pool imaging composition and method of its use |
| 05/15/1996 | EP0335910B1 Intraoperative and endoscopic tumor detection and therapy |
| 05/15/1996 | CN1122577A Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 05/14/1996 | US5516940 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 05/14/1996 | US5516658 DNA encoding cytokines that bind the cell surface receptor hek |
| 05/09/1996 | WO1996013504A1 β,β'-DIHYDROXY MESO-SUBSTITUTED CHLORINS, ISOBACTERIOCHLORINS, BACTERIOCHLORINS, AND METHODS FOR MAKING THE SAME FROM β,β'-UNSUBSTITUTED TETRAPYRROLIC MACROCYCLES |
| 05/08/1996 | EP0710720A1 Method for the production of monoclonal antibodies utilizing a germfree animal |
| 05/08/1996 | EP0710261A1 Biodegradable particles |
| 05/08/1996 | EP0710246A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
| 05/08/1996 | EP0710244A1 Immunoreactive reagents employing monoamine oxidase |
| 05/08/1996 | EP0710228A1 Hydrazino-type radionuclide chelators having an n 3?s configuration |
| 05/08/1996 | CN1122132A Ligands and metal complexes thereof |
| 05/07/1996 | US5514869 Method for estimating the probabilities of digestive tract doses due to the passage of a solid radioactive particle |
| 05/07/1996 | US5514680 Glycine receptor antagonists and the use thereof |
| 05/07/1996 | US5514409 Methods for coating invasive devices with inhibitors of thrombin |
| 05/07/1996 | US5514363 Attaching perrhenate or pertechnetate to fab fragments, medical imaging and antitumor therapy |
| 05/02/1996 | WO1996012508A2 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 05/02/1996 | WO1996012507A1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof |
| 05/02/1996 | CA2202891A1 Composition use of nucleoside analogues and gene transfection for tissue imaging and thereapy |
| 05/01/1996 | EP0467954B1 Preparation of liposome and lipid complex compositions |
| 04/30/1996 | US5512675 Methods for preparing porphyrin-like compounds |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512294 Medical diagnosis, imaging |
| 04/30/1996 | US5512256 Method of separation of yttrium-90 from strontium-90 |
| 04/25/1996 | WO1996011954A1 Tc or re radiolabelled somatostatin analogs |
| 04/25/1996 | WO1996011918A1 NOVEL N3S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS |
| 04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202382A1 Tc or re radiolabelled somatostatin analogs |
| 04/24/1996 | EP0707480A1 Antineoplastic compositions and methods of use |
| 04/24/1996 | EP0489070B1 Novel inhibitors of thrombin |
| 04/24/1996 | EP0429626B1 Synthetic peptides for use in vivo in thrombus detection |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011023A1 Liposomal agents |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | CA2200867A1 Liposomal agents |
| 04/17/1996 | EP0706396A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
| 04/17/1996 | EP0651822B1 Diagnostic method |
| 04/17/1996 | EP0553299B1 Efficient microcapsule preparation and method of use |
| 04/17/1996 | CN1120437A Boronic acid, adducts of rhenium dioxime and techmetium-99M dioxime complexes containing a biochemically active group |
| 04/16/1996 | US5508020 Technetium-99M labeled peptides for imaging |
| 04/16/1996 | US5508011 Having strontium-90 stay with crown ether bonded silica gel for period of time to produce yttrium-90 |
| 04/11/1996 | WO1996010422A1 Conjugate for treating inflammatory diseases |
| 04/11/1996 | WO1996010415A1 Preparation of mhc-peptide complexes |
| 04/11/1996 | CA2201519A1 Preparation of mhc-peptide complexes |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705105A1 Metal chelates as spacer compounds in biologically active peptides |
| 04/10/1996 | EP0547079B1 New use of a monoclonal antibody |
| 04/09/1996 | US5506345 Antihypoxic agents |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506342 Chemical reduction, crosslinking, chelating, cleaving and stabilizing |
| 04/09/1996 | US5506147 Bentiromide test for pancreatic function: administering with a stable, non-radioactive isotope of para-aminobenzoic acid; measuring natural paba and paba isotope by gas chromatography/mass spectroscopy |
| 04/04/1996 | WO1996009840A1 Contrast agent |
| 04/04/1996 | DE4435087A1 Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen Conjugate for treatment of infectious and autoimmune diseases |
| 04/04/1996 | DE4433572A1 New metal complexes of cyclic peptide(s), esp. with aspartic acid units |
| 04/04/1996 | DE4433564A1 New metal complexes of linear peptide(s) |
| 04/04/1996 | CA2201158A1 Contrast agent |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703791A1 An iodinated neuroprobe for mapping monoamine reuptake sites |
| 04/03/1996 | EP0703790A1 Iodinated paramagnetic chelates, and their use as contrast agents |
| 04/03/1996 | EP0515670B1 Hexadentate ligands useful in radiographic imaging agents |
| 04/03/1996 | EP0494247B1 Reducing non-target retention of immunoconjugates and metabolites thereof |